AI assistant
Sending…
ATAI Life Sciences N.V. — Director's Dealing 2021
Jun 18, 2021
32049_dirs_2021-06-17_92feb11c-ac0a-46d1-91a8-c2e39113637b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ATAI Life Sciences B.V. (ATAI)
CIK: 0001840904
Period of Report: 2021-06-17
Reporting Person: Kalali Amir H (Director)
More from ATAI Life Sciences N.V.
Regulatory Filings
2026
Mar 20
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 5
Capital/Financing Update
2025
Dec 5
Director's Dealing
2025
Nov 26
Interim / Quarterly Report
2025
Nov 12
Earnings Release
2025
Nov 12
Director's Dealing
2025
Nov 7